1. In vivo cutaneous antinuclear antibody positivity in palisaded neutrophilic and granulomatous dermatitis
- Author
-
Michael Murphy, Jinhong Dong, Gillian Weston, Michael Storonsky, and Micaella Zubkov
- Subjects
Pathology ,medicine.medical_specialty ,Histology ,Anti-nuclear antibody ,business.industry ,Antinuclear antibody positivity ,Autoantibody ,Connective tissue ,Dermatology ,Pathology and Forensic Medicine ,Serology ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,immune system diseases ,In vivo ,030220 oncology & carcinogenesis ,medicine ,skin and connective tissue diseases ,Granulomatous Dermatitis ,business ,Direct fluorescent antibody - Abstract
Palisaded neutrophilic and granulomatous dermatitis (PNGD) is commonly associated with underlying systemic inflammatory and neoplastic diseases, infections, and drug reactions. In vivo cutaneous antinuclear antibodies (ANA) have been described in skin biopsies from patients with known autoimmune disorders, but not previously reported in the setting of PNGD. We present two patients with systemic lupus erythematosus (SLE) and histopathologically confirmed PNGD. Direct immunofluorescence (DIF) studies revealed in vivo cutaneous ANA positivity in both patients. DIF findings in the skin mirrored serum autoantibody results. ANA positivity in skin specimens is reported as highly predictive of systemic connective tissue diseases (SCTD), although specific testing is not currently recommended as part of the laboratory work-up or diagnostic criteria for these disorders. In this case report, positive ANA results in skin biopsies of PNGD reflect the serological findings and clinical evidence of SLE in both patients. In vivo cutaneous ANA positivity is an interesting and supportive finding in PNGD in the setting of SCTD.
- Published
- 2020
- Full Text
- View/download PDF